Encompass Health (EHC)
(Delayed Data from NYSE)
$123.81 USD
-0.85 (-0.68%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $123.76 -0.05 (-0.04%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
EHC 123.81 -0.85(-0.68%)
Will EHC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EHC
Here's Why Encompass Health (EHC) is a Strong Growth Stock
Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
EHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Encompass Health Opens New Rehabilitation Hospital in The Villages
Encompass Health Flexes Its Muscle: Margins Widen as Volumes Climb
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
Other News for EHC
Keybanc Raises Price Target for Encompass Health (EHC) to $140 | EHC Stock News
Is EHC building bullish momentum? Slingshot Bullish shows up after slipping 1.1%
Encompass Health (EHC) Receives a Buy from Mizuho Securities
Encompass Health price target raised to $140 from $135 at KeyBanc
Encompass Health price target raised by $5 at KeyBanc, here's why